Real-World Outcomes of Patients with Resectable Early-Stage Non-Small Cell Lung Cancer Treated with Neoadjuvant Chemoimmunotherapy

被引：0
|
作者：
Hazim, A. [1 ]
Xiao, A. [1 ]
Singh, A. [1 ]
Chung, K. [2 ]
dos Santos, P. A. Reck [2 ]
D'Cunha, J. [2 ]
Shanshal, M. [1 ]
Dimou, A. [1 ]
Parikh, K. [1 ]
Lou, Y. [3 ]
Manochakian, R. [3 ]
Leventakos, K. [1 ]
Molina, J. [1 ]
Mansfield, A. [1 ]
Ernani, V. [2 ]
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Mayo Clin, Scottsdale, AZ USA
[3] Mayo Clin, Jacksonville, FL 32224 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
chemoimmunotherapy; neoadjuvant; non small cell lung cancer;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP.07C.16
引用
收藏
页码：S546 / S547
页数：2
相关论文
共 50 条
  • [31] Characteristics and outcomes of patients with unresected early-stage non-small cell lung cancer
    Kyasa, MJ
    Jazieh, AR
    SOUTHERN MEDICAL JOURNAL, 2002, 95 (10) : 1149 - 1152
  • [32] Real-world characteristics and treatment patterns of patients with early-stage non-small cell lung cancer in Austria: the PRATER retrospective study
    Hochmair, M.
    Terbuch, A.
    Lang, D.
    Trockenbacher, C.
    Augustin, F.
    Ghanim, B.
    Maurer, D.
    Taghizadeh, H.
    Kamhuber, C.
    Wurm, R.
    Lindenmann, J.
    Braz, P.
    Bundalo, T.
    Begic, M.
    Bauer, J.
    Reimann, P.
    Mueser, N.
    Huemer, F.
    Schintl, V.
    Bianconi, D.
    Baumgartner, B.
    Schenk, P.
    Rauter, M.
    Hoetzenecker, K.
    WIENER KLINISCHE WOCHENSCHRIFT, 2024, 136 : S530 - S531
  • [33] Real-world outcomes in patients with ALK-positive non-small cell lung cancer treated with crizotinib
    Davis, K. L.
    Kaye, J. A.
    Masters, E. T.
    Iyer, S.
    CURRENT ONCOLOGY, 2018, 25 (01) : E40 - E49
  • [34] Osimertinib as neoadjuvant therapy for resectable non-small cell lung cancer: a single-center real-world study
    Ren, S.
    Yang, L.
    Tong, Z.
    Wang, R.
    Han, W.
    Yu, F.
    Liu, W.
    Hu, Y.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [35] The role of chemotherapy in early-stage (stage I and II) resectable non-small cell lung cancer
    Pisters, KMW
    SEMINARS IN RADIATION ONCOLOGY, 2000, 10 (04) : 274 - 279
  • [36] Neoadjuvant Chemotherapy Plus Immunotherapy in Early-Stage Resectable Non-Small-Cell Lung Cancer
    Passaro, Antonio
    Attili, Ilaria
    de Marinis, Filippo
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (25) : 2871 - 2022
  • [37] Outcomes of Patients with Interstitial Lung Disease and Early-Stage Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiotherapy
    Vuong, S.
    Liu, M.
    Wallat, E.
    Bassetti, M. F.
    Baschnagel, A. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E75 - E75
  • [38] Outcomes of Resectable Locally Advanced Non-Small Cell Lung Cancer After Neoadjuvant Chemoimmunotherapy: A Single Institution Experience
    Noy, Jose
    Chang, Alexander
    Chow, Nelly P.
    De Jesus Fernandez, Javier
    Dureja, Rohan
    Cotamo, Luis Miguel
    Alnajar, Ahmed
    Nguyen, Dao M.
    Villamizar, Nestor
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (03)
  • [39] Robotic-assisted thoracic surgery following neoadjuvant chemoimmunotherapy in patients with stage III non-small cell lung cancer: A real-world prospective cohort study
    Gao, Yang
    Jiang, Juan
    Xiao, Desheng
    Zhou, Yanwu
    Chen, Yufan
    Yang, Huaping
    Wang, Lijing
    Zeng, Jun
    He, Baimei
    He, Ruoxi
    Li, Min
    Liu, Zhaoqian
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [40] Progress in the Treatment and Outcomes for Early-Stage Non-Small Cell Lung Cancer
    Shin, Jacob Y.
    Yoon, Ja Kyoung
    Marwaha, Gaurav
    LUNG, 2018, 196 (03) : 351 - 358
12345